We are combatting the world’s largest killing epidemic of chronic disease. As a charitable organization, we are leading the path forward transforming large-scale public health. We have taken on the responsibility to uphold the public bringing the latest cutting-edge expertise and ground-breaking discoveries to the forefront for health.
The advancements of science have allowed us to discover the life-saving components of the human microbiome. It is changing the future of medicine – preventing disease – saving lives. Instead of waiting to treat patients after disease has developed, we now have the tools to personalize treatments and prevent disease before it even starts.
Due to the massive gap within the system, it takes an average of fifteen years for clinical care catch up with the science. When battling cancer, heart disease, and Alzheimer’s – patients don’t have fifteen years to wait.
What we do matters. We are closing the gap to prevent disease actively working with scientists, providers, payers, and most importantly the patients. We are tenaciously driven to heal the suffering – and to put an end to the silent killer.
COLLABORATION – Strength of the collective voice.
STRATEGY – Smart and strategic advancing public health.
INTEGRITY – Transparent and dedicated to saving lives.
ACTION – Intentional and relentless driving mission and vision.
ADVOCACY – Educate and empower millions to prevent disease.
A world of healthy microbiomes.
Cassandra Isley founded the Microbiome Alliance for Disease Prevention after she, and her three daughters, were diagnosed with multiple, life-threatening, chronic diseases. In Cassandra’s early career she worked on the bench as a clinical laboratory scientist. She became Executive Director and Clinical Liaison overseeing multiple hospital divisions. For over 25 years, Cassandra has led strategic initiatives with global leaders in the healthcare, pharmaceutical, biotechnology, and life science industries.
James L. Olds, PhD served in several top-level positions including the Head of the Biological Sciences Directorate, National Science Foundation (NSF) managing an annual budget of $750 million, the White House National Science & Technology Subcommittee on Life Sciences, the White House Microbiome Interagency Working Group (MIWG) for the National Microbiome Initiative (NMI), the White House BRAIN project, the Biden Cancer Moonshot, the National Academy of Sciences Forum on Neuroscience, and George Mason University’s Krasnow Institute for Advanced Study.
Lisa Simms Booth has an extensive leadership career spanning over 25 years in the non profit sector. Lisa has served in multiple executive positions including Director of External Affairs and Operations for FasterCures, a center of the Milken Institute, Senior Director of Patient and Public Engagement with the Biden Cancer Initiative (BCI), the Biden Cancer Collaborative, and the BCI Patient Navigation Working Group. Lisa currently serves as the Executive Director of the Smith Center for Healing and the Arts. She has dedicated her career to improving the lives of cancer patients and healing the community of those suffering with disease.
Thomas R. Frantz, Esq. has an exceptional 49-year career with Williams Mullen’s law firm – President and CEO, 2010 to 2015. He currently serves as Chairman Emeritus of Williams Mullen’s Board of Directors & Partner. Tom has had the pleasure of serving the community in numerous leadership positions including Board of DroneUp, Board Miller Oil Company – D/B/A Miller Energy , Chair of GO Virginia Regional Council, Board of Visitors for the College of William & Mary, VA Business Higher Education Council, and the VA Beach Biomedical and Healthcare Taskforce.
MADP collaborative alliance is a convergence of strategic partners devoted to accelerating the microbiome ecosystem – TOGETHER. Our partners value the strategy of collaboration and the collective sharing of knowledge, expertise, and best practices to improving our nation’s health and the health of humanity across the globe.
